Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
September 25, 2018
FDA GRANTS QIDP AND FAST TRACK DESIGNATIONS TO CIDARA THERAPEUTICS’ REZAFUNGIN PROPHYLAXIS DEVELOPMENT PROGRAM
September 24, 2018
NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer
September 12, 2018
Kinestral’s Halio Smart-Tinting Glass Selected for Integration into Katerra Smart Homes & Buildings
September 12, 2018
CIDARA THERAPEUTICS APPOINTS DAVID GOLLAHER, PH.D., TO BOARD OF DIRECTORS
September 10, 2018
BIODESY ANNOUNCES NEW CEO AND $20 MILLION SERIES C FINANCING TO ACCELERATE EXPANSION INTO BIOTHERAPEUTICS DISCOVERY AND DEVELOPMENT MARKET
September 10, 2018
Flexion Therapeutics Announces Publication of Phase 2 Diabetes Data in September Issue of Rheumatology
August 21, 2018
Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of X-Linked Myotubular Myopathy
August 10, 2018
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
August 9, 2018
Viveve Reports Second Quarter 2018 Financial Results and Provides Corporate Update
August 9, 2018
CIDARA PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS
« Previous Page
1
…
73
74
75
76
77
…
118
Next Page »